CRM
PFE icon

Cramer Rosenthal McGlynn’s Pfizer PFE Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-55,503
Closed -$1.71M – 223
2016
Q4 		$1.71M Sell
55,503
-1,210,208
-96% -$36.9M 0.03% 173
2016
Q3 		$40.7M Sell
1,265,711
-588,833
-32% -$19.7M 0.62% 73
2016
Q2 		$62M Buy
1,854,544
+357,744
+24% +$11.4M 1% 25
2016
Q1 		$42.1M Buy
1,496,800
+156,435
+12% +$4.47M 0.66% 68
2015
Q4 		$41M Sell
1,340,365
-227,628
-15% -$7.16M 0.62% 71
2015
Q3 		$46.7M Sell
1,567,993
-209,893
-12% -$6.73M 0.63% 62
2015
Q2 		$56.6M Sell
1,777,886
-299,990
-14% -$9.78M 0.7% 54
2015
Q1 		$68.6M Sell
2,077,876
-241,197
-10% -$7.67M 0.77% 38
2014
Q4 		$68.5M Sell
2,319,073
-1,041,174
-31% -$29.9M 0.7% 56
2014
Q3 		$94.3M Sell
3,360,247
-560,040
-14% -$15.7M 0.94% 36
2014
Q2 		$110M Buy
3,920,287
+284,031
+8% +$8.1M 0.89% 34
2014
Q1 		$111M Sell
3,636,256
-379,722
-9% -$11.3M 0.85% 33
2013
Q4 		$117M Sell
4,015,978
-244,030
-6% -$7.1M 0.83% 39
2013
Q3 		$116M Sell
4,260,008
-95,840
-2% -$2.61M 0.87% 41
2013
Q2 		$116M Buy
+4,355,848
New +$120M 0.87% 36

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cramer Rosenthal McGlynn's PFE Position: Q1 2017 in Review

Cramer Rosenthal McGlynn sold out of Pfizer (PFE) in Q1 2017, closing a stake of 55,503 shares — an estimated $1.71M sold.

Cramer Rosenthal McGlynn first reported a position in PFE in Q2 2013 and held it in 15 quarters. The position peaked at $117M in Q4 2013. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

  • Cramer Rosenthal McGlynn reported no remaining Pfizer position as of Q1 2017 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 55,503 Pfizer shares in Q1 2017, an estimated $1.71M.
  • Cramer Rosenthal McGlynn first reported a position in Pfizer in Q2 2013 and held it in 15 quarters.
  • Cramer Rosenthal McGlynn's Pfizer position peaked at $117M in Q4 2013.
  • 2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Cramer Rosenthal McGlynn's 13F filing for Q1 2017, filed 12 May 2017.